Related Experiment Video
Updated: Dec 27, 2025
04:38
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
10.7K
Statin effects on post-stroke epilepsy and mortality - Taiwan population-based study
Peiyuan F Hsieh1, Hsin Tung2, Ching-Heng Lin3
1Taichung Veterans General Hospital, Neurological Institute, Taichung, Taiwan, ROC.
Neurological Research
|March 4, 2020
Summary
Statins did not significantly prevent post-stroke epilepsy or reduce overall mortality in Taiwan. However, statin use was associated with lower mortality risk specifically in male stroke patients.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Pharmacology
Background:
- Statins possess anti-inflammatory properties relevant to neurological conditions.
- The impact of statins on post-stroke epilepsy and mortality remains under-investigated.
Purpose of the Study:
- To investigate the association between statin use and the risk of epilepsy and mortality after stroke.
- To analyze the effects of statins in a large cohort of stroke patients.
Main Methods:
- Retrospective cohort study utilizing Taiwan's National Health Insurance Research Database (NHIRD).
- Inclusion of stroke inpatients from 2000-2009, with follow-up until 2010.
- Exclusion criteria included in-hospital mortality, seizures, prior epilepsy, pre-admission antiepileptic drug use, and age under 45.
Main Results:
- No significant difference in epilepsy risk between statin users (15.7/1000 person-years) and non-users (13.3/1000 person-years).
- No significant difference in overall mortality between statin users (104.6/1000 person-years) and non-users (66.3/1000 person-years).
- Subgroup analysis revealed significantly lower mortality risk for male statin users (60.2/1000 person-years) compared to non-users (113.0/1000 person-years).
Conclusions:
- Statins demonstrated a non-significant trend towards preventing post-stroke epilepsy in Taiwan.
- Statins appear to reduce mortality risk exclusively in male patients following a stroke.
- Further research is warranted to elucidate the precise role of statins in post-stroke outcomes.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
544
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
544
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
145
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
145